Efficacy and safety of mRNA SARS-CoV-2 vaccines in lung transplant recipients

BACKGROUND: To date, reports addressing the antibody response following mRNA SARS-CoV-2 vaccination in lung transplant (LTX) recipients are limited. Thus, the aim of this clinical study was to investigate the efficacy and safety of the vaccines in LTX recipients compared to controls. METHODS: An ope...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirama, Takashi, Akiba, Miki, Shundo, Yuki, Watanabe, Tatsuaki, Watanabe, Yui, Oishi, Hisashi, Niikawa, Hiromichi, Okada, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110371/
https://www.ncbi.nlm.nih.gov/pubmed/35599079
http://dx.doi.org/10.1016/j.jiac.2022.04.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110371/
https://www.ncbi.nlm.nih.gov/pubmed/35599079
http://dx.doi.org/10.1016/j.jiac.2022.04.019

Ejemplares similares